Psychometric Study of the Spanish Version of Two Upper Limb Assessment Scales in Chronic Stroke
Spanish-language Translation, Cross-cultural Adaption and Evaluation of the Psychometric Properties of Two Upper Limb Assessment Scales in People with Sequelae of Stroke in Chronic Phase
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of this cross-sectional study is to translate and cross-culturally adapt to Spanish the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) and the Stroke Upper Limb Capacity Scale (SULCS) and to assess their psychometric properties in Spanish people with chronic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 24, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedDecember 11, 2024
May 1, 2024
2.1 years
March 24, 2023
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change of functional impairment of the hemiparetic upper extremity: Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES).
The MESUPES assesses the quality of movement performance of the hemiparetic arm and hand in people with stroke. It is a 17-item scale divided into two subscales: one for arm function (8 items with 6 response categories (0-5)) and other for hand function ("range of motion" 6 items; and "orientation during functional tasks" 3 items, with 3 response categories (0-2)). The maximum achievable score is 58 (MESUPES-Arm maximum score is 40; MESUPES-Hand maximum score is 18), with higher scores indicating better function
Change from baseline to re-test
Change of functional impairment of the hemiparetic upper extremity: Stroke Upper Limb Capacity Scale (SULCS)
The SULCS is a 10-item scale in which the ability to perform daily activities with the hemiparetic upper limb in increasing difficulty is assessed. The scoring is dichotomous (0, unable to perform the task; 1, able to perform the task). This results in a sum score ranging from 0 to 10 with higher scores indicating better functional capacity.
Change from baseline to re-test
Secondary Outcomes (10)
Cognitive function: Montreal Cognitive Assessment (MoCA)
The cohort group will be assessed at baseline
Disability: Modified Rankin Scale (mRS)
The cohort group will be assessed at baseline
Stroke impact: Stroke Impact Scale v 3.0. (SIS)
The cohort group will be assessed at baseline
Muscle spasticity: Modified Ashworth Scale (MAS)
The cohort group will be assessed at baseline
Motor function: Fugl-Meyer Assessment- Upper Limb (FMA-UE)
The cohort group will be assessed at baseline
- +5 more secondary outcomes
Study Arms (1)
Upper extremity functional impairment due to chronic stroke
Spanish-native speakers with functional impairment of the upper extremity after stroke in chronic phase.
Interventions
There is no intervention to be administered, only collection of data through various tests and questionnaires.
Eligibility Criteria
Spanish-native speakers with functional impairment of the upper extremity after stroke in chronic phase.
You may qualify if:
- Spanish-native speakers aged between 18 and 80 years with:
- Functional impairment of the upper extremity due to hemiparesis secondary to a stroke of ≥6 months of evolution
- Clinical stability
- Sufficient cognitive capacity to give consent to participate in the study and to understand and perform the assessment tests
You may not qualify if:
- Bilateral motor impairment
- Neurological impairment other than stroke (both central and peripheral nervous systems), musculoskeletal impairment (amputation, fracture, etc.) or disabling pain (Visual Analogue Scale score \> 5) that may affect the performance of the tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Valencia
Valencia, Valencia, 46010, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Maria-Arantzazu Ruescas-Nicolau, PT, PhD
Department of Physiotherapy, University of Valencia (Spain)
- PRINCIPAL INVESTIGATOR
M.Luz Sánchez-Sánchez, PT, PhD
Department of Physiotherapy, University of Valencia (Spain)
- STUDY DIRECTOR
Lirios Dueñas, PT, PhD
Department of Physiotherapy, University of Valencia (Spain)
- STUDY CHAIR
Monja Spotti, PT, MSc
Faculty of Physiotherapy, University of Valencia (Spain)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physiotherapy
Study Record Dates
First Submitted
March 24, 2023
First Posted
May 24, 2023
Study Start
December 1, 2023
Primary Completion
January 1, 2026
Study Completion
June 1, 2026
Last Updated
December 11, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share